HCAT icon

Health Catalyst

3.97 USD
-0.32
7.46%
At close Mar 10, 4:00 PM EDT
1 day
-7.46%
5 days
-11.58%
1 month
-30.96%
3 months
-52.57%
6 months
-49.43%
Year to date
-45.91%
1 year
-53.73%
5 years
-85.70%
10 years
-89.86%
 

About: Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Employees: 1,500

0
Funds holding %
of 7,363 funds
0
Analysts bullish %
of 8 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

18,317% more call options, than puts

Call options by funds: $21M | Put options by funds: $114K

40% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 20

25% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 48

4% more funds holding

Funds holding: 159 [Q3] → 165 (+6) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]

3.0% less ownership

Funds ownership: 88.2% [Q3] → 85.2% (-3.0%) [Q4]

13% less capital invested

Capital invested by funds: $434M [Q3] → $376M (-$57.9M) [Q4]

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$5
26%
upside
Avg. target
$7.88
98%
upside
High target
$10
152%
upside

8 analyst ratings

positive
63%
neutral
38%
negative
0%
Stephens & Co.
Jeff Garro
58% 1-year accuracy
7 / 12 met price target
26%upside
$5
Equal-Weight
Maintained
6 Mar 2025
RBC Capital
Sean Dodge
39% 1-year accuracy
15 / 38 met price target
51%upside
$6
Sector Perform
Maintained
27 Feb 2025
Stifel
David Grossman
41% 1-year accuracy
9 / 22 met price target
26%upside
$5
Hold
Maintained
27 Feb 2025
Piper Sandler
Jessica Tassan
25% 1-year accuracy
6 / 24 met price target
102%upside
$8
Overweight
Maintained
11 Feb 2025
Wells Fargo
Stan Berenshteyn
30% 1-year accuracy
3 / 10 met price target
152%upside
$10
Overweight
Maintained
21 Jan 2025

Financial journalist opinion

Based on 6 articles about HCAT published over the past 30 days

Neutral
PRNewsWire
1 week ago
Signature Healthcare to Enhance Analytics by Leveraging Health Catalyst Ignite™
SALT LAKE CITY , Feb. 27, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a multi-year agreement with Signature Healthcare, an integrated healthcare delivery system serving Southeastern Massachusetts. Signature Healthcare is collaborating with Health Catalyst to integrate data resource queries and unlock referral-related data powered by Health Catalyst Ignite™, a modern data and analytics ecosystem.
Signature Healthcare to Enhance Analytics by Leveraging Health Catalyst Ignite™
Neutral
Seeking Alpha
1 week ago
Health Catalyst, Inc. (HCAT) Q4 2024 Earnings Call Transcript
Health Catalyst, Inc. (NASDAQ:HCAT ) Q4 2024 Earnings Call Transcript February 26, 2025 5:00 PM ET Company Participants Jack Knight - Vice President, Investor Relations Dan Burton - Chief Executive Officer Dan LeSueur - Chief Operating Officer Jason Alger - Chief Financial Officer Conference Call Participants Jared Haase - William Blair Anne Samuel - JPMorgan Jessica Tassan - Piper Sandler Sameer Patel - Evercore ISI John Pinney - Canaccord Genuity Daniel Grosslight - Citi David Larsen - BTIG Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Operator Welcome to the Health Catalyst's Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation.
Health Catalyst, Inc. (HCAT) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
1 week ago
Compared to Estimates, Health Catalyst (HCAT) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, Health Catalyst (HCAT) Q4 Earnings: A Look at Key Metrics
Neutral
Zacks Investment Research
1 week ago
Health Catalyst (HCAT) Misses Q4 Earnings and Revenue Estimates
Health Catalyst (HCAT) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.02 per share a year ago.
Health Catalyst (HCAT) Misses Q4 Earnings and Revenue Estimates
Neutral
GlobeNewsWire
1 week ago
Health Catalyst Reports Fourth Quarter and Year End 2024 Results
SALT LAKE CITY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2024.
Health Catalyst Reports Fourth Quarter and Year End 2024 Results
Neutral
GlobeNewsWire
2 weeks ago
Health Catalyst to Participate in Upcoming Investor Conference
SALT LAKE CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the Raymond James & Associates' 46th Annual Institutional Investors Conference, in Orlando, FL. Health Catalyst will host a fireside chat presentation on Tuesday, March 4, 2025, at 1:40 p.m.
Health Catalyst to Participate in Upcoming Investor Conference
Neutral
GlobeNewsWire
1 month ago
Health Catalyst to Participate in Upcoming Investor Conference
SALT LAKE CITY, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, and Dan LeSueur, Chief Operating Officer, will participate in the BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference, in Snowbird, UT, on Tuesday, February 11, 2025.
Health Catalyst to Participate in Upcoming Investor Conference
Positive
MarketBeat
1 month ago
Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound
The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, and data analytics. Companies at the forefront of this shift are redefining how healthcare providers manage data, deliver care, and enhance patient outcomes.
Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound
Neutral
PRNewsWire
1 month ago
Health Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare Services
SALT LAKE CITY , Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has signed a definitive agreement to acquire Upfront Healthcare Services, Inc. ("Upfront"), a next-generation patient engagement platform provider. Health Catalyst anticipates the acquisition will close in the first quarter of 2025.
Health Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare Services
Neutral
PRNewsWire
1 month ago
Health Catalyst Recognized as a Leader in Frost & Sullivan's 2024 US Population Health Management Report
SALT LAKE CITY , Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced its recognition in the Frost Radar™: US Population Health Management, 2024 report. In the report, Health Catalyst is recognized as a leader in innovation, cementing its position as a top provider in the competitive population health management (PHM) market.
Health Catalyst Recognized as a Leader in Frost & Sullivan's 2024 US Population Health Management Report
Charts implemented using Lightweight Charts™